Christine is responsible for operational medical activities across clinical trials and contributes to clinical development strategy and planning at Epitopea.

She brings more than a decade of experience in operational and strategic medical roles within the pharmaceutical and biotechnology industry. Her expertise spans early clinical and translational development of therapeutic cancer vaccines at Nykode Therapeutics, as well as Phase IV programs, medical product leadership, and team management in Oncology and Multiple Sclerosis at Biogen and Merck KGaA.

Prior to joining the industry, Christine conducted postdoctoral research at the University of California, Santa Barbara, within the Institute for Molecular, Cellular and Developmental Biology. She holds a PhD in Molecular and Cellular Biology from the University of Mainz, Germany.